The influence of ammonia and inhibition of the urea cycle by norvaline on orotic acid synthesis in five Polish Merino ewes was investigated. The sheep were exposed to 60 min of successive infusions of0·9 % NaCl, NH 4 Cl (20 µmol kg-1 min-1 ), and NH 4 Cl with DL-norvaline (10 µmol kg-1 min-1 ) solutions administered to the mesenteric vein. The average rate of orotic acid output, urea output and ammonia uptake in the liver in control conditions (infusion of 0·9 % NaCl) was: 1·09 nmol g-1 min-1 , 0·97 µmol g-1 min-1 and 0·94 µmol g-1 min-1 , respectively. Ammonia significantly stimulated the orotic acid output, urea output and ammonia uptake. At the same time liver uptake of glutamic acid, alanine and glycine increased. Norvaline as a competitive inhibitor of ornithine transcarbamylase depressed citrulline release and urea output in the liver, and elevated, although not significantly, the orotic acid output. It was concluded that ammonia stimulates the de novo synthesis of pyrimidine in the sheep liver but the participation in this effect of carbamyl phosphate generated in the urea cycle is limited.
INTRODUCTION
Ammonia is well known to stimulate orotic acid synthesis in rat (Tremblay, Crandall, Knott & Alfant, 1977; Hassan & Milner, 1979) and human liver (Fico, Motyl & Milner, 1983) . It is usually assumed that ammonia evokes an increase of orotic acid synthesis in human or rat liver as a result of mitochondrial carbamyl phosphate (CP) shunting to the cytoplasm, where is is utilized in pyrimidine synthesis (Natale & Tremblay, 1974) . Tremblay et al. ( 1977) suggested that about 80 % of orotic acid synthesized in rat liver originates from mitochondrial CP, even at physiological concentratons of ammonia and ornithine. The accumulation of mitochondrial CP and its diversion into the pyrimidine pathway is probably responsible for orotic aciduria in patients with liver ornithine transcarbamylase (OTC) and arginase deficiency (Bachman & Colombo, 1980; Naylor & Cederbaum, 1981; Flannery, Hsia & Wolf, 1982) . Fico, Hassan & Milner (1982) suggested that competitive inhibition of arginase by lysine increased shunting of mitochondrial CP for orotic acid synthesis in rat liver tissue, especially at a high ammonia concentration. Similarly, the inhibition of OTC activity by norvaline increases the rate of orotic acid synthesis in rat liver (Wendler & Tremblay, 1980) .
Comparative studies (Fico, Motyl & Milner, 1984) have shown, however, that ammonia does not exert a stimulating influence on orotic acid synthesis in cow and sheep liver slices. In this study there was a considerably lower rate of orotic acid synthesis and a higher rate of urea synthesis in ruminant liver in comparison with rat liver. There was also a lower urinary orotate: urea ratio in ruminants (Motyl, 1986) .
Up to now experiments concerning quantitative estimation of orotic acid synthesis in the liver have been undertaken in vitro and limited primarily to rat liver. In the work described pyrimidine in vivo synthesis in sheep liver has been studied. The effect of ammonia and inhibition of the urea cycle by norvaline on orotic acid synthesis was explored.
METHODS
The experiments were performed on five Polish Merino ewes, weighing 20-25 kg. Animals were fed with 0·5 kg of concentrate (95 g of crude protein, and 4·9 MJ of metabolizable energy) and 0·5 kg meadow hay (43·3 g crude protein and 3-4 MJ metabolizable energy) daily. Water was provided ad libitum. At least 7 d before the experiment, the sheep were prepared surgically by inserting catheters into the mesenteric, portal and hepatic veins, as well as the common carotid artery (Katz & Bergman, 1969a) . Prior to surgical procedure animals were premedicated with chlorpromazine hydrochloride (l ·O mg kg-1 body weight I.M.) and atropine sulphate (0· 12 mg kg-1 body weight s.c.)
and after 60 min general anaesthesia was induced with pentobarbitone infused into the jugular vein (15 mg kg-1 body weight). Animals were not given food for 24 h before the experiment. During the experiments sheep were given successive infusions (for 60 min) of 0·9 % NaCl, NH 4 Cl (20 µmol kg-1 min-1 ), and NH 4 CI (20 µmol kg-1 min-1 ) with DL-norvaline (10 µmol kg-1 min-1 ) solutions. For measurement of blood flow through the liver, the sodium salt of para-aminohippuric acid (PAH) (10 mg kg-1 min-1 ) was infused (Katz & Bergman, 1969b) . 6-Azauridine was infused into the portal vein throughout the experiment (0·083 mg kg-1 min-1 ), after an initial dose of 60 mg kg-1 • All compounds were dissolved in 0·9 % NaCl solution, adjusted to pH 7·4 and infused at l ml min-1 into the mesenteric vein. In the 60th minute of each infusion time blood samples from portal vein, hepatic vein and common carotid artery were taken simultaneously. The sheep were killed at the end of each experiment. Immediately after the liver was isolated and rinsed with saline to remove the blood residue, organ wet weight was determined with a laboratory balance. Ammonia (Okuda, Fuji & Kawashima, 1965) and PAH (Smith, Finkelstein, Aliminosa, Grawfard & Graber, 1945) were determined in whole blood. Free amino acids (Amino Acid Analyzer' Beckman 121M'), urea (Kulasek, 1972) and orotic acid (Simmonds & Harkness, 1981) were measured in the blood plasma. High-performance liquid chromatography (HPLC) was performed with an isocratic liquid chromatograph 'Beckman 330' using an ultrasphere Altex column ODS 5 µm, 4·6 x 250 mm at a stable temperature of 29 °C, and a UV detector 'Beckman 153' with a 254 nm filter for orotic acid determination. The mobile phase was 0·01 M potassium dihydrogen phosphate (pH 6) containing I% (v/v) methanol, at a flow of I ml min-1 • The concentrations of blood compounds and blood flow through the portal vein, hepatic vein and hepatic artery were used for calculation of the ammonia uptake, urea output and orotic acid output as well as amino acid uptake and output expressed in micromoles or nanomoles per minute per gram of fresh hepatic tissue.
Results were statistically calculated by variance analysis and multiple range test. The probability of differences between averages at the level P < 0·05 was taken as significant, and at the level P < 0·01 as highly significant.
RESULTS
The average (±s.E.M.) blood flow through the portal vein, hepatic artery and hepatic vein in control conditions (0·9 % NaCl infusion) was: l ·05±0·15, 0·44±0·1 and l ·49±0·19 l min-1 respectively. No significant changes in liver blood flow during NH 4 Cl, or NH 4 Cl with norvaline infusion, were noted.
The rate of ammonia uptake, urea output and orotic acid output in sheep liver in vivo is presented in Table I . Infusion ofNH 4 Cl solution caused statistically significant increases of ammonia uptake, urea output and orotic acid output in the sheep liver. Norvaline added to NH 4 Cl infusion resulted in a significant depression of urea output, as well as nonsignificant decrease of ammonia uptake and elevation of orotic acid output.
The net exchange of free amino acids (FAA) across the liver (inflow-outflow) is presented in Table 2 . The results are the means of three experiments and have not been evaluated statistically. Below are described only these changes in FAA uptake and output which were common for the three animals examined. In control conditions (0·9 % NaCl infusion) there was an hepatic uptake of alanine, phenylalanine, lysine and arginine, and output of citrulline and valine from the liver. NH 4 Cl infusion increased the liver retention of glutamic acid, glycine and alanine as well as the output of lysine. The continuation of NH4Cl infusion but with norvaline resulted in a considerable retention of this amino acid, and maintained elevated uptake of glutamic acid and alanine. The increase of glycine, citrulline, valine, leucine and lysine uptake in sheep liver was also noted.
DISCUSSION
The rate of orotic acid output in sheep liver in vivo at physiological conditions (infusion of 0·9 % NaCl) amounts on average to l · l nmol g-1 min-1 (Table 1) . Hitherto data concerning liver orotate synthesis have come from experiments with rat liver slices (Tremblay et al. 1977) , hepatocytes (Wendler & Tremblay, 1980; Barton & Hoogenraad, 1981) or homogenates (Skaper, O'Brien & Schafer, 1978) . In the only study (Fico et al. 1984) where orotate synthesis in the ruminant liver was determined the value for sheep liver slices was about 25 times less than that obtained in vivo with a physiological supply of ammonia (Table 1 ). The estimation of orotic acid synthesis in the sheep ·liver in vivo was made possible by application of 6-azauridine, an inhibitor of orotic acid conversion to uridine monophosphate (Pasternak & Handschumacher, 1959; Handschumacher, 1960) . Injection of a large dose of 6-azauridine at the beginning of the experiment, and the administration of the sustained dose throughout the whole infusion, elevated plasma orotate levels to about 10 µmo11-1 making it measurable by HPLC.
Portal hyperammonaemia significantly elevated the orotic acid output in the sheep liver (Table 1 ) . Ammonia nitrogen is not directly incorporated into the pyrimidines, but with the mediation of glutamine and aspartic acid. Glutamine is utilized in carbamyl phosphate (CP) synthesis by the action of cytoplasmic carbamyl phosphate synthetase II (CPS II). The successive reaction of CP and aspartic acid catalysed by aspartate transcarbamylase produces carbamyl aspartate, the first intermediate of the pyrimidine pathway. The increased retention of glutamic acid and alanine in the liver during portal hyperammonaemia (Table 2) is consistent with an increase of transaminations as well as enhanced glutamine and urea synthesis. Pausch, Rasenack, Haussinger & Gerok (1985) underline the importance of transamination reactions in the liver for optimal supply of aspartate as a common substrate for pyrimidine and urea synthesis. They demonstrated that the inhibition of transamination processes abolished the stimulating effect of ammonia on orotic acid synthesis in the rat liver. The increased uptake of ammonia in the present experiment was accompanied by a significant increase of urea synthesis (Table 1) . However, the quantity of urea synthesized in the liver was higher than could be expected from ammonia uptake. This suggests that the hepatic capacity for ammonia binding (Table 1) was underestimated, since the calculated ammonia balance did not take into account the ammonia turnover within the liver.
In the experimental conditions the inhibition of urea synthesis by norvaline reached on average 50% (Table 1) . Norvaline, a competitive inhibitor of OTC (Rognstad, 1977) , distinctly depressed the release of citrulline from sheep liver (Table 2 ) and decreased (P > 0·05) ammonia uptake in this organ (Table 1 ). The inhibition of urea synthesis by norvaline in portal hyperammonaemia caused a slight (P > 0·05) increase of the orotate synthesis in sheep liver (Table 1 ) . Experiments on bovine and ovine liver slices had showed the limited availability of mitochondrial CP for orotic acid synthesis in ruminant liver (Fico et al. 1984) . The present experiment confirmed these findings, since the small increase of orotate output in sheep liver is inadequate to account for degree of reduction of urea output by norvaline (Table 1 ) . It is well known that CP is synthesized in the urea cycle in quantities 1000 times higher than in the pyrimidine pathway and a relatively small shunting of CP from mitochondria to cytosol should dramatically increase the orotic acid production. Cohen, Cheung, Kyan & Raijman (1982) demonstrated that inhibition of citrulline synthesis may lead to a decrease of CPS I activity, and thus to depression of CP formation. They suggest the existence of interactions between the CPS I and OTC in mitochondria.
This hypothesis can explain a small response in orotic acid synthesis in sheep liver when citrulline synthesis was inhibited. Our results coincide with those of Pausch et al. (1985) on rat hepatocytes and perfused liver in vitro, indicating that CP utilized in pyrimidine synthesis is produced exclusively by the action of CPS II under physiological conditions.
In conclusion, it can be stated that ammonia stimulates the orotic acid synthesis in sheep liver, but the participation of mitochondrial carbamyl phosphate in this effect is limited.
